Heron Therapeutics reported $-49498000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
ALKERMES ALKS:US USD -60641000 26.18M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amarin AMRN:US USD 1.43M 39.05M
Ani Pharmaceuticals ANIP:US USD -3454000 6.78M
Arrowhead Research ARWR:US USD -83830000 10.92M
Eisai 4523:JP JPY -2181000000 9.62B
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
GlaxoSmithKline GSK:LN GBP 2.41B 591M
Immunogen IMGN:US USD -77429000 16.38M
Insmed INSM:US USD -122459000 21.52M
Merk MRK:US USD 5.56B 156M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Omeros OMER:US USD -50766000 13.33M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Roche Holding ROG:VX 11.54B 2.84B
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Veracyte VCYT:US USD -9680000 2.25M
Vertex Pharmaceuticals VRTX:US USD 1.13B 7.4M